Item 2.01
Completion of Acquisition or Disposition of Assets.
LivaNova PLC (LivaNova or the Company) previously announced that it entered into that certain Stock and Asset Purchase Agreement (the Purchase Agreement), dated March 8, 2018, with MicroPort Cardiac Rhythm B.V., a company with limited liability incorporated under the laws of the Netherlands, and MicroPort Scientific Corporation, a company with limited liability incorporated under the laws of the Cayman Islands, for the sale of LivaNovas Cardiac Rhythm Management (CRM) business franchise (the CRM Sale). The CRM Sale closed on April 30, 2018 for the purchase price of approximately $197.3 million, including certain customary closing adjustments. A description of the Purchase Agreement is included in the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on March 8, 2018, and is incorporated herein by reference.
Company
Purchase Agreement
CRM
CRM Sale
Form 8-K
